GoodRx Holdings Q2 2024 Adj. EPS $0.08 Misses $0.09 Estimate, Sales $200.610M Beat $200.441M Estimate
Portfolio Pulse from Benzinga Newsdesk
GoodRx Holdings (NASDAQ:GDRX) reported Q2 2024 earnings of $0.08 per share, missing the analyst estimate of $0.09. However, sales of $200.610 million beat the estimate of $200.441 million. Earnings increased by 14.29% year-over-year, and sales grew by 5.76%.
August 08, 2024 | 10:06 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
GoodRx Holdings reported Q2 2024 earnings of $0.08 per share, missing the analyst estimate of $0.09. Sales of $200.610 million beat the estimate of $200.441 million. Earnings increased by 14.29% year-over-year, and sales grew by 5.76%.
The mixed results, with earnings missing but sales beating estimates, suggest a neutral short-term impact on the stock price. The year-over-year growth in both earnings and sales is a positive sign, but the miss on earnings could temper investor enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100